Literature DB >> 31394110

Microbial carcinogenesis: Lactic acid bacteria in gastric cancer.

Karla Vinasco1, Hazel M Mitchell1, Nadeem O Kaakoush2, Natalia Castaño-Rodríguez3.   

Abstract

While Helicobacter pylori is a fundamental risk factor, gastric cancer (GC) aetiology involves combined effects of microbial (both H. pylori and non-H. pylori), host and environmental factors. Significant differences exist between the gastric microbiome of those with gastritis, intestinal metaplasia and GC, suggesting that dysbiosis in the stomach is dynamic and correlates with progression to GC. Most notably, a consistent increase in abundance of lactic acid bacteria (LAB) has been observed in GC patients including Streptococcus, Lactobacillus, Bifidobacterium and Lactococcus. This review summarises how LAB can influence GC by a number of mechanisms that include supply of exogenous lactate -a fuel source for cancer cells that promotes inflammation, angiogenesis, metastasis, epithelial-mesenchymal transition and immune evasion-, production of reactive oxygen species and N-nitroso compounds, as well as anti-H. pylori properties that enable colonization by other non-H. pylori carcinogenic pathobionts.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carcinogenesis; Gastric adenocarcinoma; Lactate; Microbiota; Tumor microenvironment

Mesh:

Substances:

Year:  2019        PMID: 31394110     DOI: 10.1016/j.bbcan.2019.07.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  28 in total

1.  Gut microbiome analysis as a predictive marker for the gastric cancer patients.

Authors:  Yangyang Zhang; Jian Shen; Xinwei Shi; Yaoqiang Du; Yaofang Niu; Gulei Jin; Zhen Wang; Jianxin Lyu
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-06       Impact factor: 4.813

2.  Practical Considerations in Diagnosing and Managing Early-Onset GI Cancers.

Authors:  Melissa A Lumish; Andrea Cercek
Journal:  J Clin Oncol       Date:  2022-07-15       Impact factor: 50.717

3.  Glucose Transporter-1 Cooperating with AKT Signaling Promote Gastric Cancer Progression.

Authors:  Diyuan Zhou; Linhua Jiang; Lichen Jin; Yizhou Yao; Peijie Wang; Xinguo Zhu
Journal:  Cancer Manag Res       Date:  2020-06-03       Impact factor: 3.989

Review 4.  Microbes in Tumoral In Situ Tissues and in Tumorigenesis.

Authors:  Xue Feng; Lu Han; Sijia Ma; Lanbo Zhao; Lei Wang; Kailu Zhang; Panyue Yin; Lin Guo; Wei Jing; Qiling Li
Journal:  Front Cell Infect Microbiol       Date:  2020-11-24       Impact factor: 5.293

Review 5.  Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways.

Authors:  Milad Ashrafizadeh; Hossein Rafiei; Reza Mohammadinejad; Tahereh Farkhondeh; Saeed Samarghandian
Journal:  Cancer Cell Int       Date:  2021-01-21       Impact factor: 5.722

Review 6.  Role of the Gastric Microbiome in Gastric Cancer: From Carcinogenesis to Treatment.

Authors:  Jinpu Yang; Xinxin Zhou; Xiaosun Liu; Zongxin Ling; Feng Ji
Journal:  Front Microbiol       Date:  2021-03-15       Impact factor: 5.640

Review 7.  Molecular Alterations in Gastric Intestinal Metaplasia.

Authors:  Paulius Jonaitis; Limas Kupcinskas; Juozas Kupcinskas
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 8.  Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal Microbiome.

Authors:  Joshua Bilello; Ikenna Okereke
Journal:  Biomedicines       Date:  2021-05-29

9.  Identification of potential key genes in gastric cancer using bioinformatics analysis.

Authors:  Wei Wang; Ying He; Qi Zhao; Xiaodong Zhao; Zhihong Li
Journal:  Biomed Rep       Date:  2020-02-20

10.  Alterations in Gastric Microbial Communities Are Associated with Risk of Gastric Cancer in a Korean Population: A Case-Control Study.

Authors:  Madhawa Gunathilake; Jeonghee Lee; Il Ju Choi; Young-Il Kim; Jaekyung Yoon; Woo Jun Sul; Jihyun F Kim; Jeongseon Kim
Journal:  Cancers (Basel)       Date:  2020-09-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.